Brendt Stier

WORK HISTORY

EDUCATION

SKILLS

ABOUT BRENDT STIER

Brendt is responsible for the coordination of cross-functional product development activities for alliances with sponsor partners engaged in full product development programs. Brendt has extensive experience in the pharmaceutical industry, leading product development teams from preclinical drug discovery through to product life cycle management. He has a broad range of therapeutic area experience which includes cardiovascular, diabetes, respiratory, rare disease, immuno-inflammation, urogenital, and women’s health. Brendt has a strong background in drug development while working at GlaxoSmithKline for 13 years where he led cross-functional product development teams in various therapeutic areas. During his tenure Brendt co-led and developed assets across all stages of development from preclinical assets, early phase assets, to late phase and post marketed registration. Brendt has experience in writing clinical documents such as IND briefing documents, investigator brochures, clinical study protocols, clinical study monitoring plans, study procedure manuals, clinical study reports, and clinical study manuscripts. Brendt has extensive experience in site feasibility and selection and specializes in adaptive design models for clinical development. Prior to joining the PPD consulting group, Brendt was a Senior Associate in PricewaterhouseCooper’s R&D advisory practice where he led work streams on finding innovated ways to decrease cycle times in clinical development and improve whitespace in the clinical development process. Brendt earned a B.S. in Biology from The Pennsylvania State University and an M.S. in Pharmacology from Thomas Jefferson University. Brendt also has earned an Masters in Business Administration from the Sellinger School of Business at Loyola University Maryland and is an Associate Professer at Loyola University as well.